Research Insight
Afatinib drug could inhibit growth of womb cancer, say Yale scientists
Research conducted by scientists from the Yale School of Medicine gynaecologic oncology division has demonstrated that the drug afatinib could inhibit ...
Press Releases
nLife Therapeutics receives USD 350,000 from The Michael J. Fox Foundation for Parkinson’s Research
nLife Therapeutics, an early-stage biopharmaceutical company leading developments in nOligos (neuronal specific oligonucleotides) as therapeutic agents for CNS disorders, today announces that The Michael...
Press Releases
Domain Therapeutics appoints Professor Michel Bouvier as chairman of the Scientific Advisory Board
Domain Therapeutics, a biopharmaceutical company specializing in the research and development of new medicines targeting G protein-coupled receptors (GPCRs), today announces the nomination of...
Press Releases
CleveXel Pharma partners with Guilin Pharmaceutical to develop two new anti-malarial products
CleveXel Pharma today announces that the company has entered into a new partnering agreement with Guilin Pharmaceutical, a Chinese company located in Shanghai, regarding...
News
In US, FedEx faces drug trafficking charges
The courier firm FedEx faces drug-trafficking charges after being indicted by a federal grand jury in California, in a case that highlights the growth...
News
AIDS can be brought under control by 2030: UNAIDS
AIDS can be brought under control by 2030, according to a report by the United Nations Aids agency. It said the number of new...
Industry Reports
Johnson & Johnson Reports 2014 Second-Quarter Results
Sales of $19.5 Billion increased 9.1% Versus 2013 Second Quarter; Second-Quarter EPS was $1.51 Excluding Special Items, 2014 Second-Quarter EPS of $1.66 increased 12.2%*...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read